Loading…
p28GANK associates with p300 to attenuate the acetylation of RelA
Oncoprotein p28GANK, overexpressed in hepatocellular carcinomas (HCC), binds to RelA and retains NF‐κB in the cytoplasm to suppress NF‐κB transactivation. However, the mechanism has not yet been elucidated. In this study, we clarified the mechanism of NF‐κB regulated by p28GANK. p28GANK reduced TNF‐...
Saved in:
Published in: | Molecular carcinogenesis 2015-12, Vol.54 (12), p.1626-1635 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 1635 |
container_issue | 12 |
container_start_page | 1626 |
container_title | Molecular carcinogenesis |
container_volume | 54 |
creator | Ren, Y.B. Luo, T. Li, J. Fu, J. Wang, Q. Cao, G.W. Chen, Y. Wang, H.Y. |
description | Oncoprotein p28GANK, overexpressed in hepatocellular carcinomas (HCC), binds to RelA and retains NF‐κB in the cytoplasm to suppress NF‐κB transactivation. However, the mechanism has not yet been elucidated. In this study, we clarified the mechanism of NF‐κB regulated by p28GANK. p28GANK reduced TNF‐α‐induced nuclear translocation of RelA/NF‐κB independent of HDAC3. p28GANK interacted with p300 to attenuate assembly of RelA with p300, which lessened acetylation of RelA on the lysine 310 sites. Moreover, overexpression of p28GANK attenuated the capability of NF‐κB binding to the target gene IκBα promoter, but also weakened adriamycin‐induced NF‐κB pro‐apoptotic gene Fas and FasL expression, which subsequently made p53‐deficient tumor cells resistance to adriamycin. These results present mechanistic insight into the key role of p28GANK in post‐translational regulation of RelA/NF‐κB. © 2014 Wiley Periodicals, Inc. |
doi_str_mv | 10.1002/mc.22235 |
format | article |
fullrecord | <record><control><sourceid>proquest_wiley</sourceid><recordid>TN_cdi_proquest_journals_1724293230</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3842293261</sourcerecordid><originalsourceid>FETCH-LOGICAL-p665-ef1a270463e18c919acae4355dc642b3cde7b0814b4f71ac7ded55b5446fb7a13</originalsourceid><addsrcrecordid>eNotkF1LwzAYhYMoOKfgTwh4XX3ffDTNZRk6xakguw9p-pZ1dGttMsb-vXPz6oHD4Rx4GLtHeEQA8bQJj0IIqS_YBMEWmTBKXbIJFNZmaAtzzW5iXAMgGg0TVg6imJef79zH2IfWJ4p836YVHyQATz33KdF2d8x5WhH3gdKh86ntt7xv-Dd15S27anwX6e6fU7Z8eV7OXrPF1_xtVi6yIc91Rg16YUDlkrAIFq0PnpTUug65EpUMNZkKClSVagz6YGqqta60UnlTGY9yyh7Os8PY_-woJrfud-P2-OjQCCWsFBKOrezc2rcdHdwwths_HhyC-5PjNsGd5LiP2YnyF3zHVpA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1724293230</pqid></control><display><type>article</type><title>p28GANK associates with p300 to attenuate the acetylation of RelA</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Ren, Y.B. ; Luo, T. ; Li, J. ; Fu, J. ; Wang, Q. ; Cao, G.W. ; Chen, Y. ; Wang, H.Y.</creator><creatorcontrib>Ren, Y.B. ; Luo, T. ; Li, J. ; Fu, J. ; Wang, Q. ; Cao, G.W. ; Chen, Y. ; Wang, H.Y.</creatorcontrib><description>Oncoprotein p28GANK, overexpressed in hepatocellular carcinomas (HCC), binds to RelA and retains NF‐κB in the cytoplasm to suppress NF‐κB transactivation. However, the mechanism has not yet been elucidated. In this study, we clarified the mechanism of NF‐κB regulated by p28GANK. p28GANK reduced TNF‐α‐induced nuclear translocation of RelA/NF‐κB independent of HDAC3. p28GANK interacted with p300 to attenuate assembly of RelA with p300, which lessened acetylation of RelA on the lysine 310 sites. Moreover, overexpression of p28GANK attenuated the capability of NF‐κB binding to the target gene IκBα promoter, but also weakened adriamycin‐induced NF‐κB pro‐apoptotic gene Fas and FasL expression, which subsequently made p53‐deficient tumor cells resistance to adriamycin. These results present mechanistic insight into the key role of p28GANK in post‐translational regulation of RelA/NF‐κB. © 2014 Wiley Periodicals, Inc.</description><identifier>ISSN: 0899-1987</identifier><identifier>EISSN: 1098-2744</identifier><identifier>DOI: 10.1002/mc.22235</identifier><language>eng</language><publisher>Austin: Wiley Subscription Services, Inc</publisher><subject>Cellular biology ; Chemotherapy ; Drug resistance ; hepatocellular carcinoma ; Liver cancer ; NF‐κB ; Oncology ; p28GANK ; p65 ; Proteins</subject><ispartof>Molecular carcinogenesis, 2015-12, Vol.54 (12), p.1626-1635</ispartof><rights>2014 Wiley Periodicals, Inc.</rights><rights>2015 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Ren, Y.B.</creatorcontrib><creatorcontrib>Luo, T.</creatorcontrib><creatorcontrib>Li, J.</creatorcontrib><creatorcontrib>Fu, J.</creatorcontrib><creatorcontrib>Wang, Q.</creatorcontrib><creatorcontrib>Cao, G.W.</creatorcontrib><creatorcontrib>Chen, Y.</creatorcontrib><creatorcontrib>Wang, H.Y.</creatorcontrib><title>p28GANK associates with p300 to attenuate the acetylation of RelA</title><title>Molecular carcinogenesis</title><description>Oncoprotein p28GANK, overexpressed in hepatocellular carcinomas (HCC), binds to RelA and retains NF‐κB in the cytoplasm to suppress NF‐κB transactivation. However, the mechanism has not yet been elucidated. In this study, we clarified the mechanism of NF‐κB regulated by p28GANK. p28GANK reduced TNF‐α‐induced nuclear translocation of RelA/NF‐κB independent of HDAC3. p28GANK interacted with p300 to attenuate assembly of RelA with p300, which lessened acetylation of RelA on the lysine 310 sites. Moreover, overexpression of p28GANK attenuated the capability of NF‐κB binding to the target gene IκBα promoter, but also weakened adriamycin‐induced NF‐κB pro‐apoptotic gene Fas and FasL expression, which subsequently made p53‐deficient tumor cells resistance to adriamycin. These results present mechanistic insight into the key role of p28GANK in post‐translational regulation of RelA/NF‐κB. © 2014 Wiley Periodicals, Inc.</description><subject>Cellular biology</subject><subject>Chemotherapy</subject><subject>Drug resistance</subject><subject>hepatocellular carcinoma</subject><subject>Liver cancer</subject><subject>NF‐κB</subject><subject>Oncology</subject><subject>p28GANK</subject><subject>p65</subject><subject>Proteins</subject><issn>0899-1987</issn><issn>1098-2744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNotkF1LwzAYhYMoOKfgTwh4XX3ffDTNZRk6xakguw9p-pZ1dGttMsb-vXPz6oHD4Rx4GLtHeEQA8bQJj0IIqS_YBMEWmTBKXbIJFNZmaAtzzW5iXAMgGg0TVg6imJef79zH2IfWJ4p836YVHyQATz33KdF2d8x5WhH3gdKh86ntt7xv-Dd15S27anwX6e6fU7Z8eV7OXrPF1_xtVi6yIc91Rg16YUDlkrAIFq0PnpTUug65EpUMNZkKClSVagz6YGqqta60UnlTGY9yyh7Os8PY_-woJrfud-P2-OjQCCWsFBKOrezc2rcdHdwwths_HhyC-5PjNsGd5LiP2YnyF3zHVpA</recordid><startdate>201512</startdate><enddate>201512</enddate><creator>Ren, Y.B.</creator><creator>Luo, T.</creator><creator>Li, J.</creator><creator>Fu, J.</creator><creator>Wang, Q.</creator><creator>Cao, G.W.</creator><creator>Chen, Y.</creator><creator>Wang, H.Y.</creator><general>Wiley Subscription Services, Inc</general><scope>7TM</scope><scope>7TO</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>201512</creationdate><title>p28GANK associates with p300 to attenuate the acetylation of RelA</title><author>Ren, Y.B. ; Luo, T. ; Li, J. ; Fu, J. ; Wang, Q. ; Cao, G.W. ; Chen, Y. ; Wang, H.Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p665-ef1a270463e18c919acae4355dc642b3cde7b0814b4f71ac7ded55b5446fb7a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Cellular biology</topic><topic>Chemotherapy</topic><topic>Drug resistance</topic><topic>hepatocellular carcinoma</topic><topic>Liver cancer</topic><topic>NF‐κB</topic><topic>Oncology</topic><topic>p28GANK</topic><topic>p65</topic><topic>Proteins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ren, Y.B.</creatorcontrib><creatorcontrib>Luo, T.</creatorcontrib><creatorcontrib>Li, J.</creatorcontrib><creatorcontrib>Fu, J.</creatorcontrib><creatorcontrib>Wang, Q.</creatorcontrib><creatorcontrib>Cao, G.W.</creatorcontrib><creatorcontrib>Chen, Y.</creatorcontrib><creatorcontrib>Wang, H.Y.</creatorcontrib><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Molecular carcinogenesis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ren, Y.B.</au><au>Luo, T.</au><au>Li, J.</au><au>Fu, J.</au><au>Wang, Q.</au><au>Cao, G.W.</au><au>Chen, Y.</au><au>Wang, H.Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>p28GANK associates with p300 to attenuate the acetylation of RelA</atitle><jtitle>Molecular carcinogenesis</jtitle><date>2015-12</date><risdate>2015</risdate><volume>54</volume><issue>12</issue><spage>1626</spage><epage>1635</epage><pages>1626-1635</pages><issn>0899-1987</issn><eissn>1098-2744</eissn><abstract>Oncoprotein p28GANK, overexpressed in hepatocellular carcinomas (HCC), binds to RelA and retains NF‐κB in the cytoplasm to suppress NF‐κB transactivation. However, the mechanism has not yet been elucidated. In this study, we clarified the mechanism of NF‐κB regulated by p28GANK. p28GANK reduced TNF‐α‐induced nuclear translocation of RelA/NF‐κB independent of HDAC3. p28GANK interacted with p300 to attenuate assembly of RelA with p300, which lessened acetylation of RelA on the lysine 310 sites. Moreover, overexpression of p28GANK attenuated the capability of NF‐κB binding to the target gene IκBα promoter, but also weakened adriamycin‐induced NF‐κB pro‐apoptotic gene Fas and FasL expression, which subsequently made p53‐deficient tumor cells resistance to adriamycin. These results present mechanistic insight into the key role of p28GANK in post‐translational regulation of RelA/NF‐κB. © 2014 Wiley Periodicals, Inc.</abstract><cop>Austin</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/mc.22235</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0899-1987 |
ispartof | Molecular carcinogenesis, 2015-12, Vol.54 (12), p.1626-1635 |
issn | 0899-1987 1098-2744 |
language | eng |
recordid | cdi_proquest_journals_1724293230 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Cellular biology Chemotherapy Drug resistance hepatocellular carcinoma Liver cancer NF‐κB Oncology p28GANK p65 Proteins |
title | p28GANK associates with p300 to attenuate the acetylation of RelA |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T07%3A57%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=p28GANK%20associates%20with%20p300%20to%20attenuate%20the%20acetylation%20of%20RelA&rft.jtitle=Molecular%20carcinogenesis&rft.au=Ren,%20Y.B.&rft.date=2015-12&rft.volume=54&rft.issue=12&rft.spage=1626&rft.epage=1635&rft.pages=1626-1635&rft.issn=0899-1987&rft.eissn=1098-2744&rft_id=info:doi/10.1002/mc.22235&rft_dat=%3Cproquest_wiley%3E3842293261%3C/proquest_wiley%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p665-ef1a270463e18c919acae4355dc642b3cde7b0814b4f71ac7ded55b5446fb7a13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1724293230&rft_id=info:pmid/&rfr_iscdi=true |